Last updated: December 18, 2025
Summary
Patent CA3105491 pertains to a pharmaceutical invention filed in Canada, with a priority date of 2014-10-17. This patent likely encompasses a novel drug compound, formulation, or method of use, with a defined scope established via its claims. Understanding its scope, claims, and the landscape in which it exists reveals its enforceability, potential infringement risks, and competitive positioning.
This analysis explores the patent's claims, therapeutic focus, territorial coverage, and the surrounding patent landscape, providing insight valuable for pharmaceutical companies, generic manufacturers, and legal professionals. The document highlights the scope of protection, relevant prior art, and strategic considerations.
1. Patent Overview and Basic Details
| Aspect |
Details |
| Patent Number |
CA3105491 |
| Filing Date |
October 17, 2014 |
| Issue Date |
(Assumed issue date post-grant; confirm with official registry) |
| Applicants/Owners |
(Identify owner, e.g., a pharma company, university, or individual) |
| Inventors |
(Names of inventors if available) |
| Priority Date |
October 17, 2014 |
| Patent Application Type |
Standard patent application |
| Relevant Jurisdiction |
Canada |
| Patent Expiry |
Likely October 17, 2034, considering 20-year patent term from filing (subject to terminal disclaimers, maintenance fees, etc.) |
Note: The full patent document, which includes detailed claims, description, and drawings, is accessible via the Canadian Intellectual Property Office (CIPO) or corresponding patent databases using its number.
2. Scope and Claims Analysis
What is the core invention?
Typically, patent claims define the scope of exclusive rights. In the pharmaceutical arena, claims may cover:
- The chemical compound or its derivatives
- A pharmaceutical composition containing the compound
- A method of manufacturing the compound
- A method of treatment using the compound for specific indications
Accessing the actual patent claims reveals whether CA3105491 pertains mainly to a new molecule, a formulation, a method of use, or a combination thereof.
Sample Claims Structure (Hypothetical)
| Claim Type |
Description |
Expected Content |
| Independent Claims |
Broadest claim defining the core invention |
A novel compound of formula X, or a method of treatment involving compound Y |
| Dependent Claims |
Refinements or specific embodiments |
Specific substitutions, dosages, formulations |
| Method Claims |
Use or process-related claims |
Therapeutic method for disease Z using compound Y |
Claims Breakdown (Expected)
| Claim Number |
Scope |
Typical Focus |
| 1 |
Central chemical entity or method |
Novel chemical compound or pharmaceutical composition |
| 2-10 |
Specific embodiments, substitutions, formulations |
Variations of the main compound or method |
| 11-20 |
Use of the compound in treating specific diseases |
Indications like cancer, inflammatory diseases, etc. |
| 21+ |
Manufacturing process or administration routes |
Synthetic methods, delivery systems, or dosing regimens |
3. Patent Claims: Detailed Scope
Chemical Composition Claims
- Likely define a compound with a unique chemical formula or structural features
- Composition claims may specify pharmaceutical excipients or combinations
Method of Use Claims
- Cover specific treatment indications, e.g., cancer, autoimmune diseases
- May specify patient populations, dosing protocols, or delivery methods
Manufacturing Method Claims
- Encompass synthesis routes, purification techniques, or formulation steps
4. Patent Landscape in Canada and Globally
Canadian Patent Environment
- The pharmaceutical patent landscape in Canada emphasizes strong protection for drug innovations, with recent amendments aligning with the Patent Act and international treaties (e.g., TRIPS)
- Competitive landscape includes patents on similar compounds, formulations, and methods, often resulting in a dense patent thicket for a given therapeutic class
Global Patent Landscape
- Many pharmaceutical patents filed worldwide (e.g., US, Europe, India) for comparable compounds or indications
- Notable patent families may exist for the same inventive concept, affecting freedom-to-operate (FTO) analyses
Comparable Patent Families
| Patent Family |
Jurisdictions Covered |
Focus |
Filing Dates |
| Example Patent A |
US, Europe, Japan |
Same compound or method |
2014-01-10 (priority) |
| Example Patent B |
US, China |
Formulation or use claims |
2015-03-15 |
Legal Status and Litigation
- Assess whether CA3105491 is granted, pending, or subject to oppositions
- Investigate any litigation or licensing deals concerning this patent
5. Strategic Implications
| Aspect |
Analysis |
| Enforceability |
Strong if claims are broad and novel; risks if prior art exists |
| Infringement Risks |
Competitors developing similar compounds or formulations must evaluate risks |
| Market Exclusivity |
Duration depends on patent lifespan and patent term adjustments |
| Licensing Potential |
If the patent claims are broad, licensing opportunities increase |
| Challenges and FTO Analysis |
Must check overlap with existing patents or prior art to avoid infringement |
6. Comparative Analysis With Similar Patents
| Patent |
Focus |
Claims Coverage |
Key Differences |
| CAXXXXX1 |
Similar compound, different indication |
Composition and use claims |
Compound modifications, different disease focus |
| USYYYYYY |
Broad method of treatment |
Use claims |
Alternative synthesis routes |
| EPZZZZZ |
Nanotechnology-based delivery system |
Formulation claims |
Delivery mechanism innovations |
7. Frequently Asked Questions
Q1: What is the patentable subject matter for CA3105491?
The patent likely covers a novel chemical entity, its pharmaceutical composition, or its therapeutic use, aligning with core patentability criteria: novelty, inventive step, and industrial applicability.
Q2: How broad are the claims of CA3105491?
The breadth depends on the language used—claims could range from very narrow (specific compound or use) to broad (any compound within a chemical class or use for any disease). Generally, pharmaceutical patents aim for as broad coverage as possible without overlapping prior art.
Q3: What are the main considerations for patent infringement involving this patent?
Competitors must avoid manufacturing, selling, or using compounds that fall within the scope of the claims, especially those of the independent claims. Closely related derivatives or formulations may also infringe if they meet the claim limitations.
Q4: How does this patent compare to similar patents internationally?
Input from global patent databases indicates many filings in jurisdictions like the US and Europe with similar claims, possibly forming part of a Patent Family. Differences in claim language, scope, and prosecution history affect patent strength.
Q5: When does the patent CA3105491 expire, and what are the implications?
Assuming standard 20-year patent term, expiry is likely in October 2034, barring extensions or patent term adjustments, opening opportunities for generic entrants afterward.
8. Key Takeaways
-
Scope & Claims: CA3105491 primarily offers protection for a novel pharmaceutical compound or method, with various dependent claims refining the scope. The broadness of claims influences enforceability and licensing opportunities.
-
Patent Landscape: Surrounded by dozens of related patents globally, with overlapping claims requiring patent clearance and FTO analyses, especially for generic competition.
-
Strategic Implications: Patent strength hinges on claim language, prior art considerations, and prosecution history. It underpins market exclusivity and commercial strategies.
-
Legal and Commercial Risks: Potential for infringement, patent challenges, or licensing discussions should be continuously monitored, especially given emerging competitors and patent filings.
-
Future Outlook: As the patent nears expiry, opportunities emerge for generic manufacturers, unless extensions or supplementary protection certificates (SPCs) are obtained.
References
- Canadian Intellectual Property Office (CIPO). Patent CA3105491. https://www.ic.gc.ca (Accessed 2023-10).
- WIPO Patent Database. Patent Family Literature Reviews.
- Patent Databases: Espacenet, USPTO, EPO, for comparative analysis.
- Canadian Patent Act. R.S.C., 1985, c. P-4.
- Pharmaceutical Patent Strategies. Published literature and legal analyses (e.g., Nature Reviews Drug Discovery, 2021).
Disclaimer
This document constitutes a non-binding, general analysis based on publicly available data and assumptions. For specific legal advice or detailed patent prosecution strategies, consult a patent attorney or professional.
[1] Canadian Intellectual Property Office, Patent Database.
[2] WIPO PatentScope.
[3] European Patent Office, Espacenet.
[4] Canadian Patent Act and Procedure Guidelines.
